JP2017517255A5 - - Google Patents

Download PDF

Info

Publication number
JP2017517255A5
JP2017517255A5 JP2016568573A JP2016568573A JP2017517255A5 JP 2017517255 A5 JP2017517255 A5 JP 2017517255A5 JP 2016568573 A JP2016568573 A JP 2016568573A JP 2016568573 A JP2016568573 A JP 2016568573A JP 2017517255 A5 JP2017517255 A5 JP 2017517255A5
Authority
JP
Japan
Prior art keywords
particles
micronized
diameter
jelly
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016568573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017517255A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/032078 external-priority patent/WO2015179711A1/en
Publication of JP2017517255A publication Critical patent/JP2017517255A/ja
Publication of JP2017517255A5 publication Critical patent/JP2017517255A5/ja
Priority to JP2020096350A priority Critical patent/JP7304316B2/ja
Pending legal-status Critical Current

Links

JP2016568573A 2014-05-21 2015-05-21 微粉化ホウォートンゼリー Pending JP2017517255A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020096350A JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462001600P 2014-05-21 2014-05-21
US62/001,600 2014-05-21
PCT/US2015/032078 WO2015179711A1 (en) 2014-05-21 2015-05-21 Micronized wharton's jelly

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020096350A Division JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Publications (2)

Publication Number Publication Date
JP2017517255A JP2017517255A (ja) 2017-06-29
JP2017517255A5 true JP2017517255A5 (enExample) 2018-06-14

Family

ID=54554801

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016568573A Pending JP2017517255A (ja) 2014-05-21 2015-05-21 微粉化ホウォートンゼリー
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Country Status (5)

Country Link
US (1) US20150335686A1 (enExample)
EP (1) EP3146039A4 (enExample)
JP (2) JP2017517255A (enExample)
AU (2) AU2015264025A1 (enExample)
WO (1) WO2015179711A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2623940C (en) 2005-09-27 2017-01-10 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
CA2837878A1 (en) 2011-06-10 2012-12-13 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
EP3167049A4 (en) * 2014-07-08 2017-11-29 MIMEDX Group Inc. Micronized wharton's jelly
US10201573B1 (en) * 2014-10-27 2019-02-12 Brahm Holdings, Llc Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
JP2018516869A (ja) 2015-05-20 2018-06-28 ティッシュテック,インク. 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法
US10420802B2 (en) 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
CA3050082A1 (en) 2016-04-04 2017-10-12 Omeza LLC Fish oil topical composition
EP3474869B1 (en) * 2016-06-24 2025-04-09 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
FR3070262B1 (fr) 2017-08-23 2020-10-16 Tbf Genie Tissulaire Tbf Composition comprenant de la gelee de wharton, procede de preparation et utilisations
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
CA3076485A1 (en) * 2017-09-19 2019-03-28 Gary M. Petrucci Amnion tissue preparations and methods of using
CA3075106A1 (en) * 2017-10-19 2019-04-25 Lifecell Corporation Flowable acellular tissue matrix products and methods of production
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
EP4009994A4 (en) * 2019-08-08 2023-06-21 Tissue Regeneration Therapeutics Inc. Perivascular lysates and uses thereof
US20230047934A1 (en) * 2020-03-12 2023-02-16 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
WO2022159789A1 (en) * 2021-01-25 2022-07-28 Biostem Technologies, Inc. Two-part clotting composition and methods of making and using thereof
WO2023205236A1 (en) * 2022-04-20 2023-10-26 Biostem Technologies, Inc. Multi-part processed human amniotic composition and methods of making and using thereof for treatment of peyronie's disease
CA3263067A1 (en) * 2022-07-26 2024-02-01 Biostem Tech Inc COMPOSITIONS BASED ON HUMAN UMBILICAL CORD AND INTRA-ARTICULAR THERAPY METHODS
US20240226181A1 (en) * 2023-01-11 2024-07-11 Biostem Technologies, Inc. Human umbilical cord composition for treatment of peyronie's disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) * 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
US9005646B2 (en) * 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
US8105634B2 (en) * 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
WO2008060377A2 (en) * 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
AU2008362567B2 (en) * 2008-10-10 2015-11-12 Histocell S.L. New biomaterial based on wharton's jelly from the human umbilical cord
CN102198292B (zh) * 2010-03-26 2013-06-26 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
AU2010350075B2 (en) * 2010-03-30 2016-03-03 Histocell, S.L. New biomaterial from Wharton's jelly umbilical cord
EP3744336B1 (en) * 2011-02-14 2025-01-01 MiMedx Group, Inc. Micronized placental tissue compositions and methods for making and using the same
AU2012217975B2 (en) * 2011-02-14 2015-11-19 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
ES2890126T3 (es) * 2011-12-30 2022-01-17 Amit Patel Métodos y composiciones para la obtención clínica de una célula alogénica y usos terapéuticos
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US8904664B2 (en) * 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
WO2014028657A1 (en) * 2012-08-15 2014-02-20 Mimedx Group, Inc Reinforced placental tissue grafts and methods of making and using the same
WO2015038477A1 (en) * 2013-09-10 2015-03-19 Mimedx Group, Inc. Cosmetic uses of molded placental compositions

Similar Documents

Publication Publication Date Title
JP2017517255A5 (enExample)
JP5298307B2 (ja) 半合成の血小板ゲル及びその調製方法
AU2015287920A8 (en) Micronized Wharton's Jelly
JP2017525671A5 (enExample)
JP2016216487A5 (enExample)
ME02868B (me) POSTUPCI, CEV, l UREĐAJ ZA DOBIJANJE KOMPOZICIJE ZA ZARASTANJE RANA
BRPI0513243A (pt) composições oftálmicas e métodos para tratar condições oftálmicas
Sakiyama-Elbert et al. Scaffolds to promote spinal cord regeneration
WO2013096792A1 (en) Method for repairing or replacing damaged tissue
MX388111B (es) Metodo y composicion para producir agentes regenerativos anti-inflamatorios/anti-catabolicos mejorados a partir de fluido fisiologico autologo.
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
US9821027B2 (en) Method for regenerating cartilage comprising applying a monovalent metal salt of alginic acid and SDF-1
HRP20161138T1 (hr) Farmaceutski pripravak za oralnu primjenu
JP2021500092A5 (enExample)
CN104448356A (zh) 一种空白plga微球及制备方法
JP2013173780A5 (enExample)
JP2016514716A5 (enExample)
Zhang et al. Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review
US10583216B2 (en) Scaffold compositions for tissue repair
CN118718089A (zh) 一种可注射脂肪脱细胞生物材料及其制备方法
CN104524633B (zh) 一种基于肌肉的神经支架及其制备方法
LT2014117A (lt) Trimatis porėtas celiuliozės karkasas kaulo inžinerijai ir jo gavimo būdas
US20220143268A1 (en) Novel bone putty compositions and methods of use thereof
MX380536B (es) Composicion y metodo para tratar la enfermedad de chagas.
Niu et al. Ferric Tannate-Functionalized Hierarchical Porous Materials for Hemostatic Antibacterial Non-Compressible Bleeding